BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29759420)

  • 21. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
    Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
    Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome.
    Rao VH; Meehan DT; Delimont D; Nakajima M; Wada T; Gratton MA; Cosgrove D
    Am J Pathol; 2006 Jul; 169(1):32-46. PubMed ID: 16816359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis.
    Haas M
    Arch Pathol Lab Med; 2009 Feb; 133(2):224-32. PubMed ID: 19195966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.
    Cosgrove D; Rodgers K; Meehan D; Miller C; Bovard K; Gilroy A; Gardner H; Kotelianski V; Gotwals P; Amatucci A; Kalluri R
    Am J Pathol; 2000 Nov; 157(5):1649-59. PubMed ID: 11073824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
    Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
    Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual inhibition of the endothelin and angiotensin receptor ameliorates renal and inner ear pathologies in Alport mice.
    Cosgrove D; Gratton MA; Madison J; Vosik D; Samuelson G; Meehan D; Delimont D; Phillips G; Smyth B; Pramparo T; Jarocki D; Nguyen M; Komers R; Jenkinson C
    J Pathol; 2023 Jul; 260(3):353-364. PubMed ID: 37256677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrin alpha1beta1 regulates matrix metalloproteinases via P38 mitogen-activated protein kinase in mesangial cells: implications for Alport syndrome.
    Cosgrove D; Meehan DT; Delimont D; Pozzi A; Chen X; Rodgers KD; Tempero RM; Zallocchi M; Rao VH
    Am J Pathol; 2008 Mar; 172(3):761-73. PubMed ID: 18258846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
    Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
    J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.
    Mitrofanova A; Molina J; Varona Santos J; Guzman J; Morales XA; Ducasa GM; Bryn J; Sloan A; Volosenco I; Kim JJ; Ge M; Mallela SK; Kretzler M; Eddy S; Martini S; Wahl P; Pastori S; Mendez AJ; Burke GW; Merscher S; Fornoni A
    Kidney Int; 2018 Dec; 94(6):1151-1159. PubMed ID: 30301568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.
    Ikenaga N; Peng ZW; Vaid KA; Liu SB; Yoshida S; Sverdlov DY; Mikels-Vigdal A; Smith V; Schuppan D; Popov YV
    Gut; 2017 Sep; 66(9):1697-1708. PubMed ID: 28073888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laminin-1 reexpression in Alport mouse glomerular basement membranes.
    Abrahamson DR; Prettyman AC; Robert B; St John PL
    Kidney Int; 2003 Mar; 63(3):826-34. PubMed ID: 12631063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
    Heidet L; Gubler MC
    Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
    Voskarides K; Pierides A; Deltas C
    Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV.
    López-Jiménez AJ; Basak T; Vanacore RM
    J Biol Chem; 2017 Oct; 292(41):16970-16982. PubMed ID: 28864775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inherited diseases of the glomerular basement membrane.
    Gubler MC
    Nat Clin Pract Nephrol; 2008 Jan; 4(1):24-37. PubMed ID: 18094725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.
    Cosgrove D; Liu S
    Matrix Biol; 2017 Jan; 57-58():45-54. PubMed ID: 27576055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Albumin contributes to kidney disease progression in Alport syndrome.
    Jarad G; Knutsen RH; Mecham RP; Miner JH
    Am J Physiol Renal Physiol; 2016 Jul; 311(1):F120-30. PubMed ID: 27147675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2).
    Rowbottom MW; Bain G; Calderon I; Lasof T; Lonergan D; Lai A; Huang F; Darlington J; Prodanovich P; Santini AM; King CD; Goulet L; Shannon KE; Ma GL; Nguyen K; MacKenna DA; Evans JF; Hutchinson JH
    J Med Chem; 2017 May; 60(10):4403-4423. PubMed ID: 28471663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of nuclear LOXL2 inhibition in fibroblasts and myofibroblasts in the fibrotic process of acute respiratory distress syndrome.
    Matsuo A; Tanida R; Yanagi S; Tsubouchi H; Miura A; Shigekusa T; Matsumoto N; Nakazato M
    Eur J Pharmacol; 2021 Feb; 892():173754. PubMed ID: 33248114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.
    Widjaja AA; Shekeran SG; Adami E; Ting JGW; Tan J; Viswanathan S; Lim SY; Tan PH; Hübner N; Coffman T; Cook SA
    J Am Soc Nephrol; 2022 Apr; 33(4):718-730. PubMed ID: 35140116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.